Navigation Links
Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential

Single-Dose Oral Ty800 Vaccine Immunogenic & Well-Tolerated in NIH-Sponsored Phase 1/2 Study

NEEDHAM, MA (May 18, 2007) - AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today positive preliminary results from an investigational double-blind, placebo-controlled Phase 1/2 dose-escalating clinical trial of its typhoid fever vaccine candidate, Ty800, in healthy volunteers. The researchers found the single-dose, oral vaccine to be well tolerated and immunogenic, with over 90% of vaccinated subjects generating immune responses. Based on these excellent results, AVANT plans to further develop Ty800 to compete in the expanding typhoid fever vaccine market, which currently has over $200 million in annual sales. AVANT plans to initiate its own sponsored Phase 2 dose-ranging trial of Ty800 in mid-2007.

“Typhoid fever remains endemic in many developing areas of the world, as well as being an important potential health threat for travelers and military personnel in areas affected by the disease,” said Dr. Mitchell B. Cohen, Principal Investigator in the study and Director of Gastroenterology, Hepatology and Nutrition at Cincinnati Children’s Hospital Medical Center. “The development of an effective and practical vaccine for all ages will provide an important tool for controlling this disease. A safe typhoid fever vaccine that can be easily administered could significantly reduce the morbidity and mortality associated with typhoid fever.”

“We are delighted with these results for our single-dose, oral Ty800 vaccine candidate,” said Una S. Ryan, Ph.D., President and Chief Executive Officer of AVANT Immunotherapeutics, Inc. “These results indicate that AVANT’s vaccine may have significant potential advantages over the currently licensed vaccines, which offer limited protection rates of 50-80% and require either a single needle injection or three to four oral doses over the course o
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Avants Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
2. SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
3. Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
6. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
7. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
8. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
9. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
10. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
11. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
Post Your Comments:
(Date:9/2/2014)... 2, 2014 , Elbit Imaging ... EMITF ) announced today following the Company,s announcement dated ... Medical") (TASE: EMTC-M), a subsidiary of the Company in ... basis, announced that on September 1, 2014 Gamida Cell ... the voting power ("Gamida Cell") and vast majority of ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014 Cepheid ... Flu/RSV XC, an on-demand molecular test for ... Flu B, and differentiation of RSV infection. The ... under the European Directive on In Vitro ... of tests available to eighteen. Xpert Flu/RSV XC runs ...
(Date:9/2/2014)... New York , September 2, 2014 ... " Biological Drugs Market - Global Industry Analysis, ... is expected to grow at a CAGR of 10.1% ... typically derived from living cells and are used in ... cancer, blood-related diseases, auto-immune diseases and other medical disorders. ...
Breaking Medicine Technology:Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 2Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 2CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 3CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 5CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 6
... TECH ) announced that its Board of Directors has ... the quarter ended September 30, 2010.  The quarterly dividend will ... record on November 8, 2010.  Future cash dividends will be ... Techne Corporation has two operating subsidiaries:  Research and ...
... ALTO, Calif., Oct. 28 Jazz Pharmaceuticals, Inc. (Nasdaq: ... third quarter 2010 financial results on Thursday, November 4, 2010 ... will discuss its financial results and guidance for 2010, and ... and press release may be accessed from the Investors section ...
Cached Medicine Technology:
(Date:9/2/2014)... Durable Medical Goods manufacture ThermoTek , ... financing company LeaseQ, Inc. to help customers acquire capital ... 2012, LeaseQ’s breakthrough finance shopping platform has enabled businesses ... to run their business. , Said LeaseQ Vice ... ThermoTek sales team to provide customers faster access to ...
(Date:9/2/2014)... The American Healthcare Documentation Professionals Group (AHDPG) ... its ICD-10 Medical Coding Bridge Program. The purpose of ... confidence to students who are seeking to launch an ... with the uncertainty brought on by the federal government’s ... 1st, 2015. , AHDPG’s Free-Tuition Guarantee is simple and ...
(Date:9/2/2014)... News) -- The quality of Americans, diets has improved ... the rich and poor is growing, a new study ... to date that the extensive efforts by many groups ... some payoff, but it also indicates that these efforts ... doctoral student in the department of nutrition at the ...
(Date:9/2/2014)... By Amy Norton ... -- For people who want to lose weight and boost ... than trimming dietary fat, a new study suggests. In ... those assigned to follow a low-carbohydrate diet lost more weight ... They also had bigger improvements in their cholesterol and ...
(Date:9/2/2014)... PA (PRWEB) September 02, 2014 The ... Rehabilitation Hospital returns on September 19 at The ACE ... Pennsylvania. Over the past 25 years, the Classic, organized ... than $12 million for programs and services designed to ... Magee Rehabilitation Hospital. , “The Segal Classic is ...
Breaking Medicine News(10 mins):Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 3Health News:Quality of U.S. Diet Improves, Slightly 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 3Health News:The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2
... ... can now take advantage of its platform for rapid delivery of custom business applications. ,Formotus ... the first time today at the Mobile World Congress. Formotus demonstrated its mobile software in ... Barcelona, ...
... ... Georgia has become the company’s Vice President of Product Services. Among his responsibilities, Randy ... & Notification Network, White Pine’s flagship personal health record solution. , ... (PRWEB) February 14, 2010 -- ...
... ... Society of Aesthetic Plastic Surgery indicates a 162 percent increase in aesthetic ... continuing to rise, many men and women consider a tummy tuck (abdominoplasty) ... appropriate for their needs. At his practice offering plastic surgery in ...
... , ... Training and Consulting Inc., is bringing a unique approach to the Continuous Process Improvement ... one business strategy. , ... Denver, CO (PRWEB) February 15, 2010 -- Mountain Home Training and Consulting Inc., ...
... in the Feb. 15 issue of the Journal of ... and poor sleep quality significantly increase the risk of motor ... were twice as likely to have had a crash if ... or reported having bad sleep (OR = 1.9). Eighty ...
... might not be the best way to learn what to ... popular medical dramas and found that doctors and nurses on ... according to a study released today that will be presented ... Toronto April 10 to April 17, 2010. "Television dramas ...
Cached Medicine News:Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 2Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 3Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 4Health News:Longtime Quality Assurance Executive Randy Johnson Joins White Pine Systems as Vice President of Product Services 2Health News:Is a Tummy Tuck Right for Me? Alabama Plastic Surgeon Dr. David Durst Offers Tips as the Popularity of Surgical Cosmetic Enhancement Continues to Rise 2Health News:Is a Tummy Tuck Right for Me? Alabama Plastic Surgeon Dr. David Durst Offers Tips as the Popularity of Surgical Cosmetic Enhancement Continues to Rise 3Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 2Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 3Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 4Health News:Sleep problems and sleepiness increase the risk of motor vehicle accidents in adolescents 2
... only powered 6-inch dermatome on the market. ... adult hands or a small child's face ... to run more efficiently, thus the motor ... temperature is much cooler. The Electro-Dermatome is ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
Corneal rust ring remover battery powered, extra burr 1.0 mm....
BD Visitec IOL Manipulator (Sinskey), blunt tip angled 45, 15.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles han...
Medicine Products: